Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fortive
FTV
|
+$1.27B |
| 2 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$706M |
| 3 |
iShares Russell 2000 ETF
IWM
|
+$439M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$413M |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$272M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Weyerhaeuser
WY
|
+$431M |
| 2 |
Walt Disney
DIS
|
+$223M |
| 3 |
VXX
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
|
+$213M |
| 4 |
Halliburton
HAL
|
+$211M |
| 5 |
Bristol-Myers Squibb
BMY
|
+$204M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.24% |
| 2 | Financials | 5.68% |
| 3 | Healthcare | 5.62% |
| 4 | Consumer Discretionary | 5.04% |
| 5 | Industrials | 3.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4901
Gyre Therapeutics
GYRE
$693M
| $202K | ﹤0.01% |
2,503
-2,683
| -52% | -$213K |
|
4902
CALL
Lamar Advertising Co
LAMR
$15.8B
| $202K | ﹤0.01% |
2,600
+1,400
| +117% | +$104K |
|
|
NSLR
4903
Neostellar Capital Corp
NSLR
$283M
| $202K | ﹤0.01% |
34,875
+10,087
| +41% | +$59.4K |
|
|
CNSL
4904
CALL
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $202K | ﹤0.01% |
15,500
+9,700
| +167% | +$120K |
|
|
EVOP
4905
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $202K | ﹤0.01% |
8,455
-1,871
| -18% | -$42.7K |
|
4906
Cenovus Energy
CVE
$56.4B
| $201K | ﹤0.01% |
19,877
+5,778
| +41% | +$56.4K |
|
4907
Equity Bancshares
EQBK
$1.07B
| $201K | ﹤0.01% |
5,110
+4,133
| +423% | +$170K |
|
4908
Oramed Pharmaceuticals
ORMP
$182M
| $201K | ﹤0.01% |
41,186
| – | – |
|
|
SHYF
4909
DELISTED
The Shyft Group
SHYF
| $201K | ﹤0.01% |
13,613
+8,505
| +167% | +$127K |
|
|
HNP
4910
DELISTED
Huaneng Power Intl, Inc.
HNP
| $201K | ﹤0.01% |
7,770
+1,924
| +33% | +$52.1K |
|
4911
Erie Indemnity
ERIE
$13.4B
| $200K | ﹤0.01% |
1,570
+576
| +58% | +$71.6K |
|
4912
CALL
iShares MSCI Taiwan ETF
EWT
$11.6B
| $200K | ﹤0.01% |
5,300
+1,400
| +36% | +$51.8K |
|
4913
Old Second Bancorp
OSBC
$1.31B
| $200K | ﹤0.01% |
12,979
+4,295
| +49% | +$65.4K |
|
|
HTB
4914
HomeTrust Bancshares
HTB
$837M
| $200K | ﹤0.01% |
6,890
+5,509
| +399% | +$160K |
|
|
MRNS
4915
CALL
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
| $200K | ﹤0.01% |
+5,000
| New | +$142K |
|
4916
Greenlight Captial
GLRE
$512M
| $199K | ﹤0.01% |
16,042
+13,830
| +625% | +$183K |
|
4917
Mistras Group
MG
$584M
| $199K | ﹤0.01% |
9,166
+4,113
| +81% | +$89.1K |
|
4918
NVE Corp
NVEC
$563M
| $199K | ﹤0.01% |
1,875
+1,527
| +439% | +$176K |
|
4919
CALL
Rambus
RMBS
$10.8B
| $199K | ﹤0.01% |
18,200
+4,900
| +37% | +$59.6K |
|
4920
CALL
Sonos
SONO
$1.96B
| $199K | ﹤0.01% |
+12,400
| New | +$219K |
|
4921
CALL
Toyota
TM
$223B
| $199K | ﹤0.01% |
1,600
-600
| -27% | -$75.9K |
|
4922
Westwood Holdings Group
WHG
$184M
| $199K | ﹤0.01% |
3,853
+3,204
| +494% | +$184K |
|
4923
Essential Properties Realty Trust
EPRT
$6.71B
| $198K | ﹤0.01% |
+13,973
| New | +$197K |
|
4924
CALL
H&R Block
HRB
$6.76B
| $198K | ﹤0.01% |
7,700
-112,200
| -94% | -$2.85M |
|
|
FBMS
4925
DELISTED
The First Bancshares, Inc.
FBMS
| $198K | ﹤0.01% |
5,070
+4,164
| +460% | +$163K |
|
Similar funds
Barclays's Q3 2018 Portfolio in Review
As of Q3 2018, Barclays held 7,740 positions worth $144B, up 24% from $116B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Barclays deployed $22.2B of net new capital in Q3 2018, opening 680 new positions and adding to 3,884 existing holdings. Its largest new stake was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
By sector, the portfolio is most concentrated in Technology at 8.2% of assets, up from 7.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Weyerhaeuser, an estimated $431M trimmed.
- Barclays's largest Q3 2018 buy was iPath Series B S&P GSCI Crude Oil ETN: 5,000,000 shares worth $75.7M.
- Barclays added most to Fortive in Q3 2018, an estimated $1.27B increase.
- Barclays's biggest Q3 2018 reduction was Weyerhaeuser, cutting an estimated $431M.
- Barclays fully exited Validus Hold Ltd in Q3 2018, selling an estimated $71M.
- Barclays's ten largest holdings make up 31% of its $144B portfolio in Q3 2018.
- Barclays opened 680 new positions and closed 408 in Q3 2018.
- Barclays's portfolio value rose 24% quarter-over-quarter to $144B.
Based on Barclays's 13F filing for Q3 2018, filed 14 Nov 2018.